国睿科技：10月23日召开董事会会议

Group 1 - The core point of the article is that Guorui Technology (SH 600562) held its fifth meeting of the tenth board of directors on October 23, 2025, where it reviewed the profit distribution plan for the first three quarters of 2025 [1] - For the year 2024, Guorui Technology's revenue composition is 98.67% from industrial operations and 1.33% from other businesses [1] - As of the report, Guorui Technology has a market capitalization of 36.2 billion yuan [1] Group 2 - The article mentions that Chinese innovative drugs have generated $80 billion in overseas licensing this year, highlighting a hot secondary market in biomedicine, while the primary market is facing fundraising challenges [1]